Moneycontrol PRO
krsnaa diagnostics
Jump to
25 Results Found
  • What should investors do with this diagnostic play as COVID cases drop? Oct 13, 2021 11:05 AM IST

    What should investors do with this diagnostic play as COVID cases drop?

    Krsnaa Diagnostics presents superior contract execution and scalability in radiology diagnostics

  • Krsnaa Diagnost Consolidated September 2021 Net Sales at Rs 108.26 crore, up 0% Y-o-Y Oct 12, 2021 08:55 PM IST

    Krsnaa Diagnost Consolidated September 2021 Net Sales at Rs 108.26 crore, up 0% Y-o-Y

  • Krsnaa Diagnost Standalone September 2021 Net Sales at Rs 108.26 crore, down 27.9% Y-o-Y Oct 12, 2021 08:55 PM IST

    Krsnaa Diagnost Standalone September 2021 Net Sales at Rs 108.26 crore, down 27.9% Y-o-Y

  • Bulk deals | Morgan Stanley offloads 2.5 lakh shares in Exxaro Tiles; promoter sells 20 lakh shares in KNR Constructions Aug 16, 2021 09:22 PM IST

    Bulk deals | Morgan Stanley offloads 2.5 lakh shares in Exxaro Tiles; promoter sells 20 lakh shares in KNR Constructions

    Welspun Multiventures LLP bought 5,21,565 equity shares in Spencer's Retail at Rs 104.5 per share.

  • Krsnaa Diagnostics listing: Shares close at 4% premium over issue price Aug 16, 2021 05:42 PM IST

    Krsnaa Diagnostics listing: Shares close at 4% premium over issue price

    Cumulatively Krsnaa Diagnostics traded with volume of 87.39 lakh equity shares on the BSE and NSE.

  • Krsnaa Diagnostics misses expectations on debut; what should investors do now? Aug 16, 2021 02:38 PM IST

    Krsnaa Diagnostics misses expectations on debut; what should investors do now?

    Despite the muted listing, most analysts see Krsnaa Diagnostics a strong long-term play

  • Krsnaa Diagnostics IPO shares debut at a 7% premium over issue price Aug 16, 2021 10:00 AM IST

    Krsnaa Diagnostics IPO shares debut at a 7% premium over issue price

    Krsnaa Diagnostics IPO had received healthy demand from investors, getting 64.40 times subscription during August 4-6, 2021.

  • Krsnaa Diagnostics, Windlas Biotech, Exxaro Tiles to debut on August 16: What could be listing premium? Aug 15, 2021 05:18 PM IST

    Krsnaa Diagnostics, Windlas Biotech, Exxaro Tiles to debut on August 16: What could be listing premium?

    Considering healthy response from all the category investors, Prashanth Tapse of Mehta Equities believe Windlas Biotech would list around Rs 540-550 levels, which translates to 18-20 percent premium.

  • Check latest grey market premium of Devyani International, Krsnaa Diagnostics ahead of market debut Aug 14, 2021 05:29 PM IST

    Check latest grey market premium of Devyani International, Krsnaa Diagnostics ahead of market debut

    Both the companies launched their initial public offerings on August 4 and closed on August 6 on a strong note with stellar subscription demand. Both will make a debut on the bourses on August 16.

  • Krsnaa Diagnostics IPO allotment status: Here is how to check Aug 11, 2021 03:59 PM IST

    Krsnaa Diagnostics IPO allotment status: Here is how to check

    Krsnaa Diagnostics IPO: Krsnaa Diagnostics shares were available at a premium of Rs 320 in the grey market, the IPO Watch data showed

  • Krsnaa Diagnostics IPO: Offer subscribed 64.40 times on final day, retail portion booked 42.03 times Aug 06, 2021 11:35 AM IST

    Krsnaa Diagnostics IPO: Offer subscribed 64.40 times on final day, retail portion booked 42.03 times

    Krsnaa Diagnostics shares were available at a premium of Rs 370-380 in the grey market, the IPO Watch and IPO Central data showed.

  • Krsnaa Diagnostics IPO: Issue subscribed 5.42 times on Day 2, retail portion booked 22.09 times Aug 05, 2021 11:30 AM IST

    Krsnaa Diagnostics IPO: Issue subscribed 5.42 times on Day 2, retail portion booked 22.09 times

    Krsnaa Diagnostics shares were trading at a premium of Rs 370-400 in the grey market, the IPO Watch and IPO Central data showed

  • Subscribe to Krsnaa Diagnostics: Geojit Aug 04, 2021 03:42 PM IST

    Subscribe to Krsnaa Diagnostics: Geojit

    Geojit has come out with its report on Krsnaa Diagnostics. The research firm has recommended to ''Subscribe'' the ipo in its research report as on August 03, 2021.

  • Krsnaa Diagnostics IPO sees subscription 1.98 times on day 1, retail portion booked 9.59 times Aug 04, 2021 11:45 AM IST

    Krsnaa Diagnostics IPO sees subscription 1.98 times on day 1, retail portion booked 9.59 times

    Krsnaa Diagnostics IPO: The offer comprises a fresh issue of Rs 400 crore and an offer for sale of 85,25,520 equity shares by existing shareholders

  • Krsnaa Diagnostics IPO: Should one foot the bill for this diagnostics? Aug 04, 2021 11:21 AM IST

    Krsnaa Diagnostics IPO: Should one foot the bill for this diagnostics?

    The key differentiator in the business model of Krsnaa Diagnostics is the hub-and-spoke model in radiology

  • Subscribe to Krsnaa Diagnostics: Hem Securities Aug 04, 2021 10:40 AM IST

    Subscribe to Krsnaa Diagnostics: Hem Securities

    Hem Securities has come out with its report on Krsnaa Diagnostics. The research firm has recommended to ''Subscribe'' the ipo in its research report as on August 02, 2021.

  • Subscribe to Krsnaa Diagnostics: KR Choksey Aug 04, 2021 10:32 AM IST

    Subscribe to Krsnaa Diagnostics: KR Choksey

    KR Choksey has come out with its report on Krsnaa Diagnostics. The research firm has recommended to ''Subscribe'' the ipo in its research report as on August 04, 2021.

  • Subscribe to Krsnaa Diagnostics: Arihant Capital Aug 04, 2021 10:26 AM IST

    Subscribe to Krsnaa Diagnostics: Arihant Capital

    Arihant Capital has come out with its report on Krsnaa Diagnostics. The research firm has recommended to ''Subscribe'' the ipo in its research report as on August 04, 2021.

  • Krsnaa Diagnostics IPO opens today: Should you subscribe? Aug 04, 2021 09:32 AM IST

    Krsnaa Diagnostics IPO opens today: Should you subscribe?

    Krsnaa Diagnostics IPO: Promising industry growth prospects coupled with company's strong execution track record, Religare Broking has a positive view on the company for the long term.

  • Subscribe to Krsnaa Diagnostics: Anand Rathi Aug 03, 2021 11:53 PM IST

    Subscribe to Krsnaa Diagnostics: Anand Rathi

    Anand Rathi has come out with its report on Krsnaa Diagnostics. The research firm has recommended to ''Subscribe'' the ipo in its research report as on August 03, 2021.

  • Ahead of IPO, Krsnaa Diagnostics mops up Rs 537 crore from anchor investors Aug 03, 2021 11:09 PM IST

    Ahead of IPO, Krsnaa Diagnostics mops up Rs 537 crore from anchor investors

    Marquee investors who showed strong interest in the public issue through anchor book were Kuber India Fund, Volrado Venture Partners, HSBC, Tara Emerging Asia Liquid Fund, Societe Generale, Elara India Opportunities Fund, Nomura, Stock Mother Fund, and Segantii India Mauritius.

  • Four IPOs open for subscription today, to raise over Rs 3,600 crore: Which one should you bet on? Aug 03, 2021 10:14 AM IST

    Four IPOs open for subscription today, to raise over Rs 3,600 crore: Which one should you bet on?

    Primary market investors will be spoilt for choice this week. Experts are of the view that two of them will be good for both listing gains and long-term wealth-building.

  • Krsnaa Diagnostics IPO opens tomorrow; 10 things to know about the public issue Aug 03, 2021 08:18 AM IST

    Krsnaa Diagnostics IPO opens tomorrow; 10 things to know about the public issue

    Krsnaa Diagnostics IPO will be among four public issues to open on August 4 along with Devyani International, Windlas Biotech, and Exxaro Tiles.

  • Krsnaa Diagnostics IPO price band fixed at Rs 933-954; opens on August 4 Jul 31, 2021 12:12 PM IST

    Krsnaa Diagnostics IPO price band fixed at Rs 933-954; opens on August 4

    Krsnaa Diagnostics IPO will be among four public issues to open on August 4 along with Devyani International, Windlas Biotech, and Exxaro Tiles.

  • Krsnaa Diagnostics files IPO papers with Sebi May 16, 2021 04:46 PM IST

    Krsnaa Diagnostics files IPO papers with Sebi

    New Delhi, May 16 Krsnaa Diagnostics Ltd has filed draft papers with capital markets watchdog Sebi to raise funds through an initial share sale. ..

Sections
ISO 27001 - BSI Assurance Mark